APA (7th ed.) Citation

Bergh, J., Bondarenko, I., Lichinitser, M., Liljegren, A., Greil, R., Voytko, N., . . . Giorgetti, C. (2012). First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study. American Society of Clinical Oncology.

Chicago Style (17th ed.) Citation

Bergh, J., et al. First-line Treatment of Advanced Breast Cancer with Sunitinib in Combination with Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study. American Society of Clinical Oncology, 2012.

MLA (9th ed.) Citation

Bergh, J., et al. First-line Treatment of Advanced Breast Cancer with Sunitinib in Combination with Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study. American Society of Clinical Oncology, 2012.